Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127043881 | 12704388 | 1 | I | 20160704 | 20160824 | 20160831 | 20160831 | EXP | FR-GLAXOSMITHKLINE-FR2016GSK124139 | GLAXOSMITHKLINE | 68.00 | YR | M | Y | 0.00000 | 20160831 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127043881 | 12704388 | 1 | PS | Zelitrex | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | UNK | Y | 20487 | |||||||||
| 127043881 | 12704388 | 2 | SS | Rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 367 MG, CYC | Y | Y | 0 | 367 | MG | ||||||
| 127043881 | 12704388 | 3 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 1 UNK, Z | Y | 0 | 1 | DF | TABLET | ||||||
| 127043881 | 12704388 | 4 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | Y | 0 | ||||||||||
| 127043881 | 12704388 | 5 | SS | TEVAGRASTIM | FILGRASTIM | 1 | Intravenous (not otherwise specified) | 48 MILLION IU, UNK | Y | 0 | 48 | MIU | |||||||
| 127043881 | 12704388 | 6 | SS | BENDAMUSTINE | BENDAMUSTINE | 1 | Intravenous (not otherwise specified) | 137 MG, CYC | Y | Y | 0 | 137 | MG | ||||||
| 127043881 | 12704388 | 7 | C | COTAREG | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | 0 | ||||||||||||
| 127043881 | 12704388 | 8 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127043881 | 12704388 | 2 | Chronic lymphocytic leukaemia |
| 127043881 | 12704388 | 4 | Prophylaxis |
| 127043881 | 12704388 | 5 | Neutropenia |
| 127043881 | 12704388 | 6 | Chronic lymphocytic leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127043881 | 12704388 | OT |
| 127043881 | 12704388 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127043881 | 12704388 | Dermatitis exfoliative | Dermatitis exfoliative |
| 127043881 | 12704388 | Pruritus | Pruritus |
| 127043881 | 12704388 | Pyrexia | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127043881 | 12704388 | 1 | 20160613 | 20160711 | 0 | |
| 127043881 | 12704388 | 2 | 20160613 | 20160727 | 0 | |
| 127043881 | 12704388 | 3 | 20160613 | 20160711 | 0 | |
| 127043881 | 12704388 | 5 | 20160704 | 20160704 | 0 | |
| 127043881 | 12704388 | 6 | 20160613 | 20160727 | 0 |